Invitae Company
Invitae's mission is to bring genetics to mainstream medicine to improve healthcare for billions. Invitae’s medical-grade genetic testing analyzes genes to find changes that can potentially lead to disease. The range of testing specialization includes Pregnancy, Staying Healthy, Cancer, Genetic Illness. Their pre-pregnancy genetic testing and diagnostics services intends to set new standard of care for genetic screening of inherited disorders.
Investors
Funding Status:
IPO
Investors Number:
16
Employee Number:
501-1000
Last Funding Date:
2021-04-05
Acquisitions Number:
14
Headquarters:
San Francisco, California, United States
Last Funding Type:
Post-IPO Debt
Total Funding:
1989502111
Founded Date:
2010
Industry:
Women's Longevity
Estimated Revenue:
$100M to $500M